Inventor · disambiguated record
Stephane L. Bogen
Also filed as: BOGEN STEPHANE · BOGEN STEPHANE L
48 granted patents·10 pending applications·953 citations·filing 2001–2021
98Inventor score
Files withSCHERING CORP16MERCK SHARP & DOHME15DENDREON CORP5MERCK SHARP & DOHME LLC5GIRIJAVALLABHAN VINAY4
Top patents by PatentIndex Score
58 records- 0197US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0296US7186747B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 6, 2007·47 cites·31 claims
- 0396US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0495US7592316B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2007·Granted Sep 22, 2009·34 cites·6 claims
- 0595US7425576B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Sep 16, 2008·20 cites·24 claims
- 0695US7205330B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2005·Granted Apr 17, 2007·54 cites·29 claims
- 0795US7173057B2Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virusSCHERING CORP·Filed 2005·Granted Feb 6, 2007·44 cites·29 claims
- 0895US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0994US9242988B22′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Granted Jan 26, 2016·17 cites·17 claims
- 1094US9156872B22′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 13, 2015·45 cites·21 claims
- 1194US9061041B22′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Jun 23, 2015·49 cites·43 claims
- 1294US7423058B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2006·Granted Sep 9, 2008·15 cites·22 claims
- 1394US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 1493US7192957B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 20, 2007·28 cites·28 claims
- 1592US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 1690US7884107B2Substituted piperidines that increase P53 activity and the uses thereofMERCK·Filed 2007·Granted Feb 8, 2011·32 cites·36 claims
- 1789USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 1887US9150603B22′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 6, 2015·14 cites·21 claims
- 1986US7816326B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2007·Granted Oct 19, 2010·9 cites·18 claims
- 2084US11730748B2Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseasesMSD INT GMBH·Filed 2020·Granted Aug 22, 2023·1 cites·11 claims
- 2184US10086000B2Tricyclic compounds as inhibitors of mutant IDH enzymesMERCK SHARP & DOHME·Filed 2015·Granted Oct 2, 2018·3 cites·17 claims
- 2283US8067379B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseBENNETT FRANK·Filed 2005·Granted Nov 29, 2011·8 cites·43 claims
- 2382US7619094B2Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virusSCHERING CORP·Filed 2006·Granted Nov 17, 2009·5 cites·33 claims
- 2480US12331018B2Pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 17, 2025·1 cites·6 claims
- 2580US9732111B22′-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·2 cites·17 claims
- 2678US11098029B25-alkyl pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME·Filed 2020·Granted Aug 24, 2021·1 cites·12 claims
- 2778US10899788B2Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Granted Jan 26, 2021·3 cites·17 claims
- 2876US9416154B25′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesVERMA VISHAL A·Filed 2012·Granted Aug 16, 2016·4 cites·19 claims
- 2975US8962611B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Feb 24, 2015·1 cites·20 claims
- 3075US8846657B2Substituted imidazopyridines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Sep 30, 2014·1 cites·30 claims
- 3170US9540377B22,6,7,8 substituted purines as HDM2 inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 10, 2017·2 cites·15 claims
- 3268US9765107B2Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2014·Granted Sep 19, 2017·1 cites·13 claims
- 3365US10508108B2Tricyclic compounds as inhibitors of mutant IDH enzymesMERCK SHARP & DOHME·Filed 2015·Granted Dec 17, 2019·1 cites·20 claims
- 3465US8859776B2Substituted piperidines that increase p53 activity and the uses thereofBOGEN STEPHANE L·Filed 2010·Granted Oct 14, 2014·2 cites·44 claims
- 3564US2022040214A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2021·Application pending·0 cites
- 3658US7718691B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted May 18, 2010·0 cites·33 claims
- 3757US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 3856US7759499B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Jul 20, 2010·0 cites·22 claims
- 3955US12497362B2Cyclopentapyrrole orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 16, 2025·0 cites·13 claims
- 4054US2024002397A13-amino pyrrolidine and piperidine macrocyclic orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 4153US11680060B2Bicycloheptane pyrrolidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2021·Granted Jun 20, 2023·0 cites·37 claims
- 4253US2011117057A1Novel peptides as ns3-serine protease inhibitors of hepatitis c virusSCHERING CORP·Filed 2010·Application pending·0 cites
- 4353US2005059606A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2004·Application pending·0 cites
- 4452US9457039B22′-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2013·Granted Oct 4, 2016·0 cites·16 claims
- 4552US2019365788A1Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseasesIDENIX PHARMACEUTICALS LLC·Filed 2017·Application pending·0 cites
- 4651US7595299B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2005·Granted Sep 29, 2009·0 cites·5 claims
- 4750US2014336222A1SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOFMERCK SHARP & DOHME·Filed 2014·Application pending·0 cites
- 4849US12312332B2Heteroaryl pyrrolidine and piperidine orexin receptor agonistsMERCK SHARP & DOHME LLC·Filed 2020·Granted May 27, 2025·0 cites·11 claims
- 4947US2020179428A1Cyclic phosphate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesBOGEN STEPHANE·Filed 2017·Application pending·0 cites
- 5045US7635694B2Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Dec 22, 2009·0 cites·22 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephane L. Bogen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →